Chen J Y, Sun X H
Department of Ophthalmology, Eye & ENT Hospital of Fudan University, NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai 200031, China.
Zhonghua Yan Ke Za Zhi. 2022 Nov 11;58(11):863-867. doi: 10.3760/cma.j.cn112142-20220909-00446.
Glaucoma is a leading cause of irreversible blindness in the world. The reduction of intraocular pressure is the main clinical treatment. Due to the limitations of traditional filter surgery, a variety of minimally invasive glaucoma surgery (MIGS) procedures have been applied in clinical practice in recent years. Quite a few of them have been carried out in China and achieved good results. At the same time, domestic technology enterprises are actively engaged in the development, innovation and localization of the MIGS equipment. However, there are still some problems in MIGS in China, which need to be paid attention to and require corresponding clinical research, so as to make it a new highlight in the clinical diagnosis and treatment of glaucoma.
青光眼是全球不可逆性失明的主要原因。降低眼压是主要的临床治疗方法。由于传统滤过性手术存在局限性,近年来多种微创青光眼手术(MIGS)已应用于临床实践。其中不少手术已在中国开展并取得了良好效果。与此同时,国内科技企业正积极投身于MIGS设备的研发、创新及国产化。然而,中国的MIGS仍存在一些问题,需要予以关注并开展相应的临床研究,以便使其成为青光眼临床诊疗的新亮点。